Request Your Free Information Brief Now:

"Unlocking Market Access in Europe: Advantages of localized oral solid dose (OSD) production"

When developing high-potency oral solid dose (OSD) products for the European market, complexity is a given--but delays don’t have to be.

With the right expertise and local insight, you can streamline development, avoid regulatory surprises, and reach patients faster.

At our FDA-approved Center of Excellence in Bourgoin, France, we help pharmaceutical and biotech companies reduce risk and accelerate progress through:

• Development and commercial manufacturing under one roof
• A specialized early development center supporting high-potency programs
• Advanced simulation tools to support confident decision-making
• Deep regulatory knowledge, including QP release across EU markets

Explore real-world examples of how our team helped solve critical OSD challenges in our latest blog post—delivering speed, consistency, and confidence at every stage. Download now.

Offered Free by: Thermo Fisher Scientific
See All Resources from: Thermo Fisher Scientific